Patrick Soon-Shiong

CIK: 0001189020

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (23.1%)

Derivative conversions

Awards (A)2 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)8 (61.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PDSB

PDS Biotechnology Corp

Director10% Owner

IBRX

ImmunityBio, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (13 total)

IBRX
ImmunityBio, Inc.
Mar 31, 2026
Conversion(C)
Indirect
4.6M shares at avg. $5.43$25.0M
IBRX
ImmunityBio, Inc.
Feb 22, 2026
Tax Payment(F)
Direct
58.2K shares at avg. $8.70$506K
IBRX
ImmunityBio, Inc.
Feb 22, 2026
Exercise(M)
Direct
114.3K shares-
IBRX
ImmunityBio, Inc.
Feb 10, 2026
Exercise(M)
Direct
274.1K shares-
IBRX
ImmunityBio, Inc.
Feb 10, 2026
Tax Payment(F)
Direct
118.6K shares at avg. $6.93$822K
IBRX
ImmunityBio, Inc.
Feb 22, 2025
Exercise(M)
Direct
114.3K shares-
IBRX
ImmunityBio, Inc.
Feb 22, 2025
Tax Payment(F)
Direct
42.1K shares at avg. $3.42$144K
IBRX
ImmunityBio, Inc.
Feb 10, 2025
Award(A)
Restricted Stock Units
Direct
822.4K shares-
IBRX
ImmunityBio, Inc.
Feb 10, 2025
Award(A)
Stock Option (right to buy)
Direct
2.8M shares-
IBRX
ImmunityBio, Inc.
Dec 10, 2024
Conversion(C)
Indirect
103.7M shares at avg. $1.94$200.7M
IBRX
ImmunityBio, Inc.
Dec 10, 2024
Conversion(C)
Indirect
13.5M shares at avg. $2.28$30.7M
IBRX
ImmunityBio, Inc.
Dec 10, 2024
Other(J)
Amended and Restated Promissory Note
Indirect
0 shares-
IBRX
ImmunityBio, Inc.
Dec 10, 2024
Other(J)
Second Amended and Restated Convertible Promissory Note
Indirect
0 shares at avg. $505000000.00-

		Type	Shares	Price		Ownership
Mar 31, 2026	IBRX ImmunityBio, Inc.	Conversion(C)	4,606,596	$5.43	$24,999,996	Indirect
Feb 22, 2026	IBRX ImmunityBio, Inc.	Tax Payment(F)	58,170	$8.70	$506,079	Direct
Feb 22, 2026	IBRX ImmunityBio, Inc.	Exercise(M)	114,329	-	$0	Direct
Feb 10, 2026	IBRX ImmunityBio, Inc.	Exercise(M)	274,122	-	$0	Direct
Feb 10, 2026	IBRX ImmunityBio, Inc.	Tax Payment(F)	118,560	$6.93	$821,621	Direct
Feb 22, 2025	IBRX ImmunityBio, Inc.	Exercise(M)	114,329	-	-	Direct
Feb 22, 2025	IBRX ImmunityBio, Inc.	Tax Payment(F)	42,071	$3.42	$143,883	Direct
Feb 10, 2025	IBRX ImmunityBio, Inc.	Award(A) Restricted Stock Units	822,368	-	-	Direct
Feb 10, 2025	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	2,812,500	-	-	Direct
Dec 10, 2024	IBRX ImmunityBio, Inc.	Conversion(C)	103,710,088	$1.94	$200,679,020	Indirect
Dec 10, 2024	IBRX ImmunityBio, Inc.	Conversion(C)	13,475,172	$2.28	$30,723,392	Indirect
Dec 10, 2024	IBRX ImmunityBio, Inc.	Other(J) Amended and Restated Promissory Note	0	-	-	Indirect
Dec 10, 2024	IBRX ImmunityBio, Inc.	Other(J) Second Amended and Restated Convertible Promissory Note	0	$505000000.00	-	Indirect

1-13 of 13 transactions

About SOON-SHIONG PATRICK

SOON-SHIONG PATRICK (SEC CIK 0001189020) files insider reports with the SEC as Director of PDS Biotechnology Corp (PDSB) and Director of ImmunityBio, Inc. (IBRX).

Signal8 holds 7 ownership filings by SOON-SHIONG PATRICK (1 Form 3, 6 Form 4), filed between Dec 12, 2024 and Sep 21, 2026. Those filings report 13 transactions, from Dec 10, 2024 to Mar 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SOON-SHIONG PATRICK's filings is in PRINCETON, NJ.

Recent filings by SOON-SHIONG PATRICK

Mar 31, 2026: Conversion of IBRX shares (Form 4, code C).
Feb 22, 2026: Tax withholding of IBRX shares (Form 4, code F).
Feb 22, 2026: Option exercise of IBRX shares (Form 4, code M).
Feb 10, 2026: Option exercise of IBRX shares (Form 4, code M).
Feb 10, 2026: Tax withholding of IBRX shares (Form 4, code F).

Other insiders filing for PDS Biotechnology Corp (PDSB)

Dawson John Andrew, Director
Ramsdell Deborah, Director
Wendel Bruce, Director
Banaag Arnold James, Director
Trochimiuk Janetta, Principal Accounting Officer
BEDU-ADDO FRANK, President/CEO

How to read Form 4 transaction codes